Difficulty: Medium
Average Score: 86%
Practice
A 27-year-old woman presents with hypersomnia (sleeps approximately 15 hours per day) and hyperphagia (has gained 6 kg). She is feeling discouraged and disinterested and reports a lack of energy. She has recently been thinking about death. Although she felt able to 'conquer the world' 2 months ago, she now feels lost and confused. Previously, she had 2 jobs and was training for a marathon. She was convinced she would make it to the Olympics, given that she required only 4 hours of sleep to recuperate. What agent would MOST likely stabilize her current condition?
Correct answer
A
Rationale
The correct answer is A) Quetiapine. Quetiapine, an atypical antipsychotic, is commonly used in the treatment of bipolar depression. The symptoms described in the scenario - hypersomnia, hyperphagia, low energy, feelings of discouragement, disinterest, and suicidal ideation - are indicative of a depressive episode in bipolar disorder. Quetiapine helps stabilize mood, reduce depressive symptoms, and prevent manic episodes.
Option B) Divalproex is a mood stabilizer commonly used in bipolar disorder, but it is more effective in treating manic episodes rather than depressive symptoms.
Option C) Bupropion is an antidepressant that can exacerbate manic symptoms in bipolar disorder and is not the first-line treatment for bipolar depression.
Option D) Pramipexole is a dopamine agonist primarily used in Parkinson's disease and restless leg syndrome, not as a first-line treatment for bipolar depression.
Educationally, understanding the rationale behind each option helps students grasp the importance of proper medication selection based on the patient's symptoms and diagnosis. It reinforces the need for accurate assessment and appropriate treatment in psychiatric emergencies to ensure optimal patient outcomes.
Option B) Divalproex is a mood stabilizer commonly used in bipolar disorder, but it is more effective in treating manic episodes rather than depressive symptoms.
Option C) Bupropion is an antidepressant that can exacerbate manic symptoms in bipolar disorder and is not the first-line treatment for bipolar depression.
Option D) Pramipexole is a dopamine agonist primarily used in Parkinson's disease and restless leg syndrome, not as a first-line treatment for bipolar depression.
Educationally, understanding the rationale behind each option helps students grasp the importance of proper medication selection based on the patient's symptoms and diagnosis. It reinforces the need for accurate assessment and appropriate treatment in psychiatric emergencies to ensure optimal patient outcomes.